Delsym Cough Plus Chest Congestion Dm

Delsym Cough Plus Chest Congestion Dm

Delsym Cough Plus Chest Congestion Dm Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

NexHATM (hyaluronate sodium) injectable solution is indicated in the treatment of joint dysfunction of the carpus or fetlock in horses due to non-infectious synovitis associated with equine osteoarthritis.

History

There is currently no drug history available for this drug.

Other Information

NexHATM (hyaluronate sodium) injectable solution is a clear, colorless solution of low viscosity. NexHATM injectable solution is pyrogen free, sterile and does not contain a preservative. It is administered by intravenous injection. Hyaluronic acid, the conjugate acid of hyaluronate sodium, is extracted from the capsule of Streptococcus spp. and purified, resulting in a form which is essentially free of protein and nucleic acids. NexHATM injectable solution is supplied in 4 mL (40 mg) vials.
Each mL contains 10 mg hyaluronate sodium, 8.5 mg sodium chloride, 0.223 mg sodium phosphate dibasic and 0.04 mg sodium phosphate monobasic. The pH is adjusted to between 6.5 and 8.0 with sodium hydroxide or hydrochloric acid.

Delsym Cough Plus Chest Congestion Dm Manufacturers


  • Reckitt Benckiser Llc
    Delsym Cough Plus Chest Congestion Dm (Dextromethorphan Hydrobromide And Guaifenesin) Liquid [Reckitt Benckiser Llc]

Login To Your Free Account